Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00303355 · ClinicalTrials.gov registry record
Measurement of Jugular Venous Pulse in Critically Ill Patients.
A clinical trial, sponsored by University of Chicago.
- Terminated
- Registry status
- 36
- Enrollment target
NCT00303355: Clinical Trial study, sponsored by University of Chicago.
NCT00303355 is a clinical trial that was terminated before completion, run by University of Chicago. The registered enrollment target is 36 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00303355 was terminated before completion, sponsored by University of Chicago.
- TERMINATED
- Registry status
- 36 participants
- Enrollment target
Study Summary
To assess the utility of clinical bedside examination for the measurement of jugular venous pulse in critically ill patients.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2002-09 |
| Est. Completion | 2004-09 |
Why NCT00303355 stopped before completion
NCT00303355 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 36 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00303355 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00303355 about?
NCT00303355 is a clinical study titled "Measurement of Jugular Venous Pulse in Critically Ill Patients.". To assess the utility of clinical bedside examination for the measurement of jugular venous pulse in critically ill patients.
What is the current status of trial NCT00303355?
This trial is currently terminated. The enrollment target is 36 participants. The study started on 2002-09. Estimated completion is 2004-09.
Who is sponsoring clinical trial NCT00303355?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00929006 · 36 participants · Early Phase 1
Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism
- NCT01891318 · 36 participants · Phase 1
Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study
- NCT02291848 · 36 participants · Phase 1
Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma
- NCT02366819 · 36 participants · Phase 4
Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia